Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 purchases).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Damora Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Damora Therapeutics, Inc.Listing unverified | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Damora Therapeutics, Inc.Listing unverified | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Damora Therapeutics, Inc.Listing unverified | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Damora Therapeutics, Inc.Listing unverified | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Jade Biosciences, Inc.Listing unverified | Award | $12.2M | SEC | ||
Jade Biosciences, Inc.Listing unverified | AwardD (derivative) | $7.8M | SEC | ||
Zenas BioPharma, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Spyre Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Spyre Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Viridian Therapeutics, Inc.\DEListing on record | Buy | $30M | conv 57 | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Viridian Therapeutics, Inc.\DEListing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Viridian Therapeutics, Inc.\DEListing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Viridian Therapeutics, Inc.\DEListing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Viridian Therapeutics, Inc.\DEListing on record | Buy | $10M | conv 44First in 12mo | SEC | |
Spyre Therapeutics, Inc.Listing on record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Spyre Therapeutics, Inc.Listing on record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Spyre Therapeutics, Inc.Listing on record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
MedGen, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
MedGen, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
MedGen, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
MedGen, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC |